COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2seventy bio, Inc. | COMMON STOCK | 901384107 | 21,356 | 833,236 | SH | | SOLE | | 833,236 | 0 | 0 |
AbCellera Biologics Inc. | COM | 00288U106 | 149,438 | 10,450,180 | SH | | SOLE | | 10,450,180 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 978,196 | 41,910,704 | SH | | SOLE | | 41,910,704 | 0 | 0 |
Achilles Therapeutics plc | SPONSORED ADS | 00449L102 | 12,983 | 2,591,366 | SH | | SOLE | | 2,591,366 | 0 | 0 |
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 36,866 | 9,830,877 | SH | | SOLE | | 9,830,877 | 0 | 0 |
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 16,198 | 3,410,106 | SH | | SOLE | | 3,410,106 | 0 | 0 |
Aerovate Therapeutics, Inc. | COM | 008064107 | 21,597 | 1,831,789 | SH | | SOLE | | 1,831,789 | 0 | 0 |
Affimed N.V. | COM | N01045108 | 14,645 | 2,653,169 | SH | | SOLE | | 2,653,169 | 0 | 0 |
Akero Therapeutics, Inc. | COM | 00973Y108 | 2,504 | 118,378 | SH | | SOLE | | 118,378 | 0 | 0 |
Albireo Pharma, Inc. | COM | 01345P106 | 2,434 | 104,521 | SH | | SOLE | | 104,521 | 0 | 0 |
Alector, Inc. | COM | 014442107 | 4,940 | 239,228 | SH | | SOLE | | 239,228 | 0 | 0 |
Aligos Therapeutics, Inc. | COM | 01626L105 | 24,647 | 2,076,400 | SH | | SOLE | | 2,076,400 | 0 | 0 |
Alkermes plc | SHS | G01767105 | 34,890 | 1,500,000 | SH | | SOLE | | 1,500,000 | 0 | 0 |
Allakos Inc. | COM | 01671P100 | 6,883 | 703,050 | SH | | SOLE | | 703,050 | 0 | 0 |
Altimmune, Inc. | COM | 02155H200 | 9,820 | 1,072,038 | SH | | SOLE | | 1,072,038 | 0 | 0 |
Amarin Corporation plc | SPONSORED ADR | 023111206 | 71,342 | 21,169,805 | SH | | SOLE | | 21,169,805 | 0 | 0 |
AnaptysBio, Inc. | COM | 032724106 | 14,844 | 427,179 | SH | | SOLE | | 427,179 | 0 | 0 |
argenx SE | SPONSORED ADR | 04016X101 | 392,058 | 1,119,557 | SH | | SOLE | | 1,119,557 | 0 | 0 |
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 610,982 | 4,541,604 | SH | | SOLE | | 4,541,604 | 0 | 0 |
Athira Pharma, Inc. | COM | 04746L104 | 10,507 | 806,367 | SH | | SOLE | | 806,367 | 0 | 0 |
Atreca, Inc. | CL A COM | 04965G109 | 10,704 | 3,532,760 | SH | | SOLE | | 3,532,760 | 0 | 0 |
aTyr Pharma, Inc. | COM | 002120202 | 4,669 | 625,000 | SH | | SOLE | | 625,000 | 0 | 0 |
Axsome Therapeutics, Inc. | COM | 05464T104 | 23,082 | 610,970 | SH | | SOLE | | 610,970 | 0 | 0 |
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 3,161,454 | 11,668,897 | SH | | SOLE | | 11,668,897 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | COM | 079481404 | 371 | 249,123 | SH | | SOLE | | 249,123 | 0 | 0 |
BioAtla, Inc. | COM | 09077B104 | 16,195 | 825,000 | SH | | SOLE | | 825,000 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 176,045 | 12,710,818 | SH | | SOLE | | 12,710,818 | 0 | 0 |
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 673,271 | 7,620,494 | SH | | SOLE | | 7,620,494 | 0 | 0 |
Biomea Fusion, Inc. | COM | 09077A106 | 3,908 | 524,617 | SH | | SOLE | | 524,617 | 0 | 0 |
bluebird bio, Inc. | COM | 09609G100 | 24,972 | 2,499,715 | SH | | SOLE | | 2,499,715 | 0 | 0 |
Burning Rock Biotech Limited | SPONSORED ADS | 12233L107 | 1,993 | 209,131 | SH | | SOLE | | 209,131 | 0 | 0 |
Cabaletta Bio, Inc. | COM | 12674W109 | 2,509 | 662,063 | SH | | SOLE | | 662,063 | 0 | 0 |
Centessa Pharmaceuticals plc | SPONSORED ADS | 152309100 | 12,693 | 1,127,273 | SH | | SOLE | | 1,127,273 | 0 | 0 |
Cerus Corporation | COM | 157085101 | 93,387 | 13,713,195 | SH | | SOLE | | 13,713,195 | 0 | 0 |
ChemoCentryx, Inc. | COM | 16383L106 | 59,394 | 1,631,266 | SH | | SOLE | | 1,631,266 | 0 | 0 |
Chinook Therapeutics, Inc. | COM | 16961L106 | 38,069 | 2,334,102 | SH | | SOLE | | 2,334,102 | 0 | 0 |
Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 23,509 | 827,480 | SH | | SOLE | | 827,480 | 0 | 0 |
CymaBay Therapeutics, Inc. | COM | 23257D103 | 7,336 | 2,170,464 | SH | | SOLE | | 2,170,464 | 0 | 0 |
Cyteir Therapeutics, Inc. | COM | 23284P103 | 9,240 | 812,640 | SH | | SOLE | | 812,640 | 0 | 0 |
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 23,383 | 14,614,264 | SH | | SOLE | | 14,614,264 | 0 | 0 |
Denali Therapeutics Inc. | COM | 24823R105 | 3,958 | 88,738 | SH | | SOLE | | 88,738 | 0 | 0 |
Design Therapeutics, Inc. | COM | 25056L103 | 30,758 | 1,436,636 | SH | | SOLE | | 1,436,636 | 0 | 0 |
DICE Therapeutics, Inc. | COM | 23345J104 | 14,888 | 588,235 | SH | | SOLE | | 588,235 | 0 | 0 |
Edgewise Therapeutics, Inc. | COM | 28036F105 | 7,640 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
Entrada Therapeutics, Inc. | COM | 29384C108 | 80,540 | 4,704,419 | SH | | SOLE | | 4,704,419 | 0 | 0 |
Evofem Biosciences, Inc. | COM | 30048L104 | 1,013 | 2,697,110 | SH | | SOLE | | 2,697,110 | 0 | 0 |
FibroGen, Inc. | COM | 31572Q808 | 8,180 | 580,150 | SH | | SOLE | | 580,150 | 0 | 0 |
Foghorn Therapeutics Inc. | COM | 344174107 | 1,030 | 45,027 | SH | | SOLE | | 45,027 | 0 | 0 |
Forma Therapeutics Holdings, Inc. | SHS | 34633R104 | 28,794 | 2,024,876 | SH | | SOLE | | 2,024,876 | 0 | 0 |
Fulgent Genetics, Inc. | COM | 359664109 | 20,263 | 201,444 | SH | | SOLE | | 201,444 | 0 | 0 |
Gamida Cell Ltd. | SHS | M47364100 | 1,551 | 610,626 | SH | | SOLE | | 610,626 | 0 | 0 |
Genetron Holdings Limited | ADS | 37186H100 | 2,777 | 455,306 | SH | | SOLE | | 455,306 | 0 | 0 |
Global Blood Therapeutics, Inc. | COM | 37890U108 | 97,023 | 3,314,765 | SH | | SOLE | | 3,314,765 | 0 | 0 |
Harmony Biosciences Holdings, Inc. | COM | 413197104 | 5,270 | 123,600 | SH | | SOLE | | 123,600 | 0 | 0 |
Heron Therapeutics, Inc. | COM | 427746102 | 74,242 | 8,131,678 | SH | | SOLE | | 8,131,678 | 0 | 0 |
HOOKIPA Pharma Inc. | COM | 43906K100 | 1,632 | 700,481 | SH | | SOLE | | 700,481 | 0 | 0 |
Horizon Therapeutics Public Ltd Co | SHS | G46188101 | 64,560 | 599,110 | SH | | SOLE | | 599,110 | 0 | 0 |
IGM Biosciences, Inc. | COM | 449585108 | 92,568 | 3,156,102 | SH | | SOLE | | 3,156,102 | 0 | 0 |
Immatics N.V. | SHS | N44445109 | 59,455 | 4,423,731 | SH | | SOLE | | 4,423,731 | 0 | 0 |
Immunocore Holdings plc | ADS | 45258D105 | 86,310 | 2,520,730 | SH | | SOLE | | 2,520,730 | 0 | 0 |
Incyte Corporation | COM | 45337C102 | 2,467,566 | 33,618,063 | SH | | SOLE | | 33,618,063 | 0 | 0 |
Inozyme Pharma, Inc. | COM | 45790W108 | 730 | 106,999 | SH | | SOLE | | 106,999 | 0 | 0 |
Insmed Incorporated | COM PAR $.01 | 457669307 | 58,729 | 2,156,001 | SH | | SOLE | | 2,156,001 | 0 | 0 |
Instil Bio, Inc. | COM | 45783C101 | 66,621 | 3,893,700 | SH | | SOLE | | 3,893,700 | 0 | 0 |
Invitae Corporation | COM | 46185L103 | 150,768 | 9,873,488 | SH | | SOLE | | 9,873,488 | 0 | 0 |
Iteos Therapeutics, Inc. | COM | 46565G104 | 7,000 | 150,346 | SH | | SOLE | | 150,346 | 0 | 0 |
Karuna Therapeutics, Inc. | COM | 48576A100 | 9,166 | 69,966 | SH | | SOLE | | 69,966 | 0 | 0 |
Kezar Life Sciences, Inc. | COM | 49372L100 | 2,335 | 139,676 | SH | | SOLE | | 139,676 | 0 | 0 |
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 32,951 | 2,799,577 | SH | | SOLE | | 2,799,577 | 0 | 0 |
Kodiak Sciences Inc. | COM | 50015M109 | 1,244,681 | 14,681,304 | SH | | SOLE | | 14,681,304 | 0 | 0 |
Krystal Biotech, Inc. | COM | 501147102 | 56,501 | 807,735 | SH | | SOLE | | 807,735 | 0 | 0 |
Kura Oncology, Inc. | COM | 50127T109 | 4,258 | 304,158 | SH | | SOLE | | 304,158 | 0 | 0 |
Kymera Therapeutics, Inc. | COM | 501575104 | 151,407 | 2,384,742 | SH | | SOLE | | 2,384,742 | 0 | 0 |
Leap Therapeutics, Inc. | COM | 52187K101 | 1,813 | 559,705 | SH | | SOLE | | 559,705 | 0 | 0 |
Legend Biotech Corporation | SPONSORED ADS | 52490G102 | 116,012 | 2,489,003 | SH | | SOLE | | 2,489,003 | 0 | 0 |
LogicBio Therapeutics, Inc. | COM | 54142F102 | 1,043 | 451,478 | SH | | SOLE | | 451,478 | 0 | 0 |
MacroGenics, Inc. | COM | 556099109 | 7,103 | 442,579 | SH | | SOLE | | 442,579 | 0 | 0 |
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 127,043 | 1,499,213 | SH | | SOLE | | 1,499,213 | 0 | 0 |
Merus N.V. | COM | N5749R100 | 64,792 | 2,037,469 | SH | | SOLE | | 2,037,469 | 0 | 0 |
Mirati Therapeutics, Inc. | COM | 60468T105 | 206,801 | 1,409,784 | SH | | SOLE | | 1,409,784 | 0 | 0 |
Neoleukin Therapeutics, Inc. | COM | 64049K104 | 18,421 | 3,821,740 | SH | | SOLE | | 3,821,740 | 0 | 0 |
Neurocrine Biosciences, Inc. | COM | 64125C109 | 57,658 | 676,975 | SH | | SOLE | | 676,975 | 0 | 0 |
NexImmune, Inc. | COM | 65344D109 | 1,356 | 294,117 | SH | | SOLE | | 294,117 | 0 | 0 |
NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 5,168 | 291,801 | SH | | SOLE | | 291,801 | 0 | 0 |
Novavax, Inc. | COM | 670002401 | 6,891 | 48,168 | SH | | SOLE | | 48,168 | 0 | 0 |
Nurix Therapeutics, Inc. | COM | 67080M103 | 71,046 | 2,454,082 | SH | | SOLE | | 2,454,082 | 0 | 0 |
Opthea Limited | SPONSORED ADS | 68386J208 | 24,115 | 3,196,191 | SH | | SOLE | | 3,196,191 | 0 | 0 |
Otonomy, Inc. | COM | 68906L105 | 16,317 | 7,844,692 | SH | | SOLE | | 7,844,692 | 0 | 0 |
Oyster Point Pharma, Inc. | COM | 69242L106 | 1,122 | 61,424 | SH | | SOLE | | 61,424 | 0 | 0 |
Pacific Biosciences of California, Inc. | COM | 69404D108 | 111,404 | 5,444,963 | SH | | SOLE | | 5,444,963 | 0 | 0 |
Passage Bio, Inc. | COM | 702712100 | 744 | 117,161 | SH | | SOLE | | 117,161 | 0 | 0 |
Prelude Therapeutics Inc. | COM | 74065P101 | 126,042 | 10,123,824 | SH | | SOLE | | 10,123,824 | 0 | 0 |
Protara Therapeutics, Inc. | COM STK | 74365U107 | 1,348 | 199,671 | SH | | SOLE | | 199,671 | 0 | 0 |
Reata Pharmaceuticals, Inc. | CL A | 75615P103 | 5,906 | 223,976 | SH | | SOLE | | 223,976 | 0 | 0 |
Relmada Therapeutics, Inc. | COM | 75955J402 | 11,155 | 495,113 | SH | | SOLE | | 495,113 | 0 | 0 |
Replimune Group, Inc. | COM | 76029N106 | 16,081 | 593,395 | SH | | SOLE | | 593,395 | 0 | 0 |
Revolution Medicines, Inc. | COM | 76155X100 | 5,593 | 222,222 | SH | | SOLE | | 222,222 | 0 | 0 |
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 38,555 | 3,863,239 | SH | | SOLE | | 3,863,239 | 0 | 0 |
Sarepta Therapeutics, Inc. | COM | 803607100 | 11,117 | 123,456 | SH | | SOLE | | 123,456 | 0 | 0 |
Seagen Inc. | COM | 81181C104 | 7,249,714 | 46,893,364 | SH | | SOLE | | 46,893,364 | 0 | 0 |
Sera Prognostics, Inc. | CLASS A COM | 81749D107 | 1,385 | 201,562 | SH | | SOLE | | 201,562 | 0 | 0 |
Surrozen, Inc. | COM | 86889P109 | 16,100 | 2,500,000 | SH | | SOLE | | 2,500,000 | 0 | 0 |
Surrozen, Inc. | W EXP 8/11/2026 | 86889P117 | 958 | 833,333 | SH | | SOLE | | 833,333 | 0 | 0 |
Syndax Pharmaceuticals, Inc. | COM | 87164F105 | 2,424 | 110,729 | SH | | SOLE | | 110,729 | 0 | 0 |
Talis Biomedical Corporation | COM | 87424L108 | 30,576 | 7,624,835 | SH | | SOLE | | 7,624,835 | 0 | 0 |
Tango Therapeutics, Inc. | COM | 87583X109 | 8,205 | 750,000 | SH | | SOLE | | 750,000 | 0 | 0 |
TCR2 Therapeutics Inc. | COM | 87808K106 | 3,509 | 753,064 | SH | | SOLE | | 753,064 | 0 | 0 |
Travere Therapeutics, Inc. | COM | 89422G107 | 82,847 | 2,669,054 | SH | | SOLE | | 2,669,054 | 0 | 0 |
Tricida, Inc. | COM | 89610F101 | 12,285 | 1,285,014 | SH | | SOLE | | 1,285,014 | 0 | 0 |
TScan Therapeutics, Inc. | COM | 89854M101 | 6,413 | 1,425,000 | SH | | SOLE | | 1,425,000 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 37,373 | 444,444 | SH | | SOLE | | 444,444 | 0 | 0 |
Verastem, Inc. | COM | 92337C104 | 44,058 | 21,491,630 | SH | | SOLE | | 21,491,630 | 0 | 0 |
Verve Therapeutics, Inc. | COM | 92539P101 | 52,227 | 1,416,530 | SH | | SOLE | | 1,416,530 | 0 | 0 |
Vincerx Pharma, Inc. | COM | 92731L106 | 2,460 | 241,379 | SH | | SOLE | | 241,379 | 0 | 0 |
Xenon Pharmaceuticals Inc. | COM | 98420N105 | 23,481 | 751,639 | SH | | SOLE | | 751,639 | 0 | 0 |
Zymeworks Inc. | COM | 98985W102 | 28,002 | 1,708,472 | SH | | SOLE | | 1,708,472 | 0 | 0 |
Apellis Pharmaceuticals, Inc. | Note 3.5% 9/15/2026 | 03753UAB2 | 47,968 | 31,754,000 | PRN | | SOLE | | 31,754,000 | 0 | 0 |
Insmed Incorporated | Note 0.75% 6/1/2028 | 457669AB5 | 43,336 | 40,000,000 | PRN | | SOLE | | 40,000,000 | 0 | 0 |
Invitae Corporation | Note 2.0% 9/1/2024 | 46185LAB9 | 9,623 | 10,300,000 | PRN | | SOLE | | 10,300,000 | 0 | 0 |
Sarepta Therapeutics, Inc. | DBCV 1.5% 11/15/2024 | 803607AB6 | 42,695 | 29,174,000 | PRN | | SOLE | | 29,174,000 | 0 | 0 |
Tricida, Inc. | Note 3.5% 5/15/2027 | 89610FAB7 | 14,828 | 27,500,000 | PRN | | SOLE | | 27,500,000 | 0 | 0 |